TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bioplanum AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
365
|
474
|
314 |
Financial expenses |
3
![]() |
3
|
1 |
Earnings before taxes |
148
|
74
|
94 |
EBITDA |
150
|
76
|
95 |
Total assets |
173
|
236
|
246 |
Current assets |
160
|
223
|
231 |
Current liabilities |
24
|
122
|
111 |
Equity capital |
150
|
114
|
135 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
86.7%
|
48.3%
|
54.9% |
Turnover per employee |
365
|
474
|
314 |
Profit as a percentage of turnover |
40.5%
|
15.6%
|
29.9% |
Return on assets (ROA) |
87.3%
|
32.6%
|
38.6% |
Current ratio |
666.7%
|
182.8%
|
208.1% |
Return on equity (ROE) |
98.7%
|
64.9%
|
69.6% |
Change turnover |
-111
|
185
|
60 |
Change turnover % |
-23%
|
64%
|
23% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.